Abstract:BACKGROUND Endoscopic retrograde cholangiopancreatography (ERCP) is an accurate diagnostic method for choledocholithiasis and treatment option for stone removal. Additionally, ursodeoxycholic acid (UDCA) can dissolve cholesterol stones and prevent their development and reappearance by lowering the cholesterol concentration in bile. Despite these treatment options, there are still patients who experience stone recurrence. AIM To analyze the risk factors for choledocholithiasis recurrence after ERCP retrograde cholangiopancreatography and the effect of UDCA intervention. METHODS The clinical data of 100 patients with choledochal stones who were hospitalized at the Yixing People’s Hospital and underwent ERCP for successful stone extraction between June 2020 and December 2022 were retrospectively collected. According to the post-ERCP treatment plan, 100 patients were classified into UDCA (n = 47) and control (n = 53) groups. We aimed to assess the clinical efficacy and rate of relapse in the two patient populations. We then collected information (basic demographic data, clinical characteristics, and serum biochemical indicators) and determined the factors contributing to relapse using logistic regression analysis. Our secondary goal was to determine the effects of UDCA on liver function after ERCP. RESULTS Compared to the control group, the UDCA group demonstrated a higher clinical effectiveness rate of 92.45% vs 78.72% (P < 0.05). No significant differences were observed in liver function indices, including total bilirubin, direct bilirubin, gamma-glutamyl transpeptidase, alanine aminotransferase, alkaline phosphatase, and aspartate aminotransferase, between the two groups before treatment. After treatment, all liver function indices were significantly reduced. Comparing the control vs UDCA groups, the UDCA group exhibited significantly lower levels of all indices (55.39 ± 6.53 vs 77.31 ± 8.52, 32.10 ± 4.62 vs 45.39 ± 5.69, 142.32 ± 14.21 vs 189.63 ± 16.87, 112.52 ± 14.25 vs 149.36 ± 15.36, 122.61 ± 16.00 vs 171.33 ± 22.09, 96.98 ± 10.44 vs 121.35 ± 11.57, respectively, all P 3 (OR: 4.23, 95%CI: 1.17-15.26), and positive bile culture (OR: 7.61, 95%CI: 2.07-27.91) were independent factors that influenced the relapse of common bile duct stones after ERCP (P < 0.05). Furthermore, postoperative UDCA was identified as a preventive factor (OR: 0.07; 95%CI: 0.08-0.09). CONCLUSION The intervention effect of UDCA after ERCP for common bile duct stones is adequate, providing new research directions and references for the prevention and treatment of stone recurrence.

Biliary Tube Irrigation after Endoscopic Retrograde Cholangiopancreatography to Prevent the Recurrence in Patients with Choledocholithiasis

Intraoperative ERCP and endoscopic sphincterotomy combined with laparoscopic cholecystectomy for treatment of cholelithiasis with choledocholithiasis

Endoscopic Retrograde Cholangiopancreatography for Biliary Stricture with Bile Duct Stone after Liver Transplantation

Causes associated with recurrent choledocholithiasis following therapeutic endoscopic retrograde cholangiopancreatography: A large sample sized retrospective study.

Risk factors for recurrence of common bile duct stones after surgical treatment and effect of ursodeoxycholic acid intervention

Risk factors for recurrence of common bile duct stones after endoscopic retrograde cholangiopancreatography

Risk Factors for Recurrent Common Bile Duct Stones After Endoscopic Retrograde Cholangiopancreatography

Utility of ERCP in the Treatment of Biliary Stricture Combined with Bile Duct Stone after Liver Transplantation

Endoscopic retrograde cholangiopancreatography in management of biliary complications after liver transplantation

Risk factors of postoperative recurrence of common bile duct stones in patients with endoscopic retrograde cholangiopancreatography lithotomy: a meta-analysis

Role of Percutaneous Transhepatic Cholangial Drainage in 29 Patients with Non-Anastomotic Biliary Stricture Following the Treatment of Endoscopic Retrograde Cholangio-Pancreatography after Liver Transplantation

Risk Factors for Recurrence after Endoscopic Treatment of Common Bile Duct Stones

Risk factors related to bile duct stone recurrence after endoscopic retrograde cholangio-pancreatography:a Meta analysis

Evaluation of Endoscopic Therapy in the Treatment of Acute Biliary Pancreatitis

Endoscopic retrograde cholangiopancreatography for biliary complications after liver transplantation

Endoscopic retrograde cholangiopancreatography in the treatment of biliary complications after orthotopic liver transplantation

Biliary occlusive disease after liver transplantation with endoscopic retrograde cholangiopancreatography plus percutaneous transhepatic cholangiodrainage

Evaluation of Clinical Indications of Three Treatments for Choledocholithiasis with Acute Cholangitis

Efficacy of endoscopic nasobiliary drainage for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and cholangitis after repeated clearance of common bile duct stones: experience from a Chinese center

A retrospective comparison of endoscopic nasobiliary drainage (ENBD) and endoscopic retrograde biliary drainage (ERBD) in the treatment of acute cholangitis

Risk factors for common bile duct stones recurrence in patients undergoing ERCP and LC